Canada markets closed

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
146.950.00 (0.00%)
At close: 07:14PM BST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3-9.17%
S&P500 52-Week Change 323.89%
52 Week High 3167.80
52 Week Low 3131.22
50-Day Moving Average 3151.22
200-Day Moving Average 3150.54

Share Statistics

Avg Vol (3 month) 3108.2k
Avg Vol (10 day) 317.89k
Shares Outstanding 51.5B
Implied Shares Outstanding 6N/A
Float 81.76B
% Held by Insiders 10.10%
% Held by Institutions 172.66%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 36.06
Trailing Annual Dividend Yield 34.12%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 11.02%
Operating Margin (ttm)28.29%

Management Effectiveness

Return on Assets (ttm)7.71%
Return on Equity (ttm)56.24%

Income Statement

Revenue (ttm)54.4B
Revenue Per Share (ttm)30.77
Quarterly Revenue Growth (yoy)0.70%
Gross Profit (ttm)N/A
EBITDA 26.12B
Net Income Avi to Common (ttm)5.95B
Diluted EPS (ttm)6.97
Quarterly Earnings Growth (yoy)472.80%

Balance Sheet

Total Cash (mrq)18.07B
Total Cash Per Share (mrq)10.23
Total Debt (mrq)74.36B
Total Debt/Equity (mrq)924.06%
Current Ratio (mrq)0.94
Book Value Per Share (mrq)4.53

Cash Flow Statement

Operating Cash Flow (ttm)22.69B
Levered Free Cash Flow (ttm)23.61B